Markel Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.1M | Buy |
49,550
+4,550
| +10% | +$1.84M | 0.17% | 81 |
|
2025
Q1 | $22.4M | Buy |
45,000
+3,900
| +9% | +$1.94M | 0.2% | 75 |
|
2024
Q4 | $21.4M | Buy |
41,100
+5,700
| +16% | +$2.97M | 0.19% | 74 |
|
2024
Q3 | $21.9M | Buy |
35,400
+6,000
| +20% | +$3.71M | 0.2% | 74 |
|
2024
Q2 | $16.3M | Buy |
29,400
+4,700
| +19% | +$2.6M | 0.16% | 80 |
|
2024
Q1 | $14.4M | Buy |
24,700
+5,100
| +26% | +$2.96M | 0.14% | 84 |
|
2023
Q4 | $10.4M | Buy |
19,600
+6,000
| +44% | +$3.18M | 0.11% | 94 |
|
2023
Q3 | $6.88M | Buy |
13,600
+5,400
| +66% | +$2.73M | 0.08% | 104 |
|
2023
Q2 | $4.28M | Hold |
8,200
| – | – | 0.05% | 111 |
|
2023
Q1 | $4.73M | Hold |
8,200
| – | – | 0.06% | 108 |
|
2022
Q4 | $4.52M | Buy |
8,200
+400
| +5% | +$220K | 0.06% | 108 |
|
2022
Q3 | $3.96M | Buy |
7,800
+1,300
| +20% | +$659K | 0.06% | 106 |
|
2022
Q2 | $3.53M | Buy |
6,500
+4,550
| +233% | +$2.47M | 0.05% | 106 |
|
2022
Q1 | $1.15M | Buy |
1,950
+1,650
| +550% | +$975K | 0.01% | 118 |
|
2021
Q4 | $200K | Buy |
+300
| New | +$200K | ﹤0.01% | 120 |
|